Effect of Ultra-low Dose Naloxone During Supraclavicular Brachial Plexus Block on Post-operative Opioi

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 18, 2017

Primary Completion Date

April 10, 2018

Study Completion Date

April 25, 2018

Conditions
Upper Extremity Trauma
Interventions
DRUG

Bupivacaine plus naloxone

Patients received 20 mL bupivacaine 0.5% plus 100 ng naloxone (1ml) in 2ml saline.(naloxone ampoule 0.4mg will dilute in 400ml of saline then 1ml of it will dilute in 10 ml saline, so each ml will have 100ng naloxone)

DRUG

Bupivacaine

Patients will be injected ultrasound guided in their brachial plexus by 20 mL bupivacaine 0.5% plus 3 ml of saline

Trial Locations (1)

050

Mansoura University, Central Hospital, emergency Unit, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03372486 - Effect of Ultra-low Dose Naloxone During Supraclavicular Brachial Plexus Block on Post-operative Opioi | Biotech Hunter | Biotech Hunter